Massachusetts General Hospital
Boston, Massachusetts, 02116, United States
NCT Number: NCT00451230
The goal of this this study is to elucidate the role of the HPA axis in the pathophysiology of cocaine dependence
Looking for future studies?
Notify Me21 year–49 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02116, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
National Institute on Drug Abuse (NIDA)
Nih
Elucidating the Role of the Hypothalamic-Pituitary-Adrenal (HPA) Axis in the Mechanisms Underlying Cocaine Dependence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05857852
Chemically-Induced Disorders, Cocaine Abuse
Charlottesville, Virginia, United States
View Trial DetailsNCT04907357
Chemically-Induced Disorders, Cocaine Abuse
Winston-Salem, North Carolina, United States
View Trial DetailsNCT02111798
Chemically-Induced Disorders, Cocaine Dependence
Baltimore, Maryland, United States
View Trial DetailsNCT04994821
Chemically-Induced Disorders, Cocaine Dependence
New York, United States
View Trial Details